{"transactions":[{"id":776761,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-16T01:28:36.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2027 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":27000,"derivative":{"exercise_price":9.76,"expiration_date":"2036-05-15","underlying":"Ordinary Shares","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0000905148-26-002469","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000090514826002469/form4.xml","form_type":"4"}},{"id":1144944,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-16T20:51:38.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":20183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2026 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":20183,"derivative":{"exercise_price":6.885,"expiration_date":"2035-05-14","underlying":"Ordinary Shares","underlying_shares":20183},"source":{"system":"sec-edgar","filing":"0000905148-25-001831","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000090514825001831/form4.xml","form_type":"4"}},{"id":1510718,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-17T20:38:51.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2025 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":22.39,"expiration_date":"2034-05-15","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000905148-24-001536","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000090514824001536/form4.xml","form_type":"4"}},{"id":1884202,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"other":true,"other_text":"Chair of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-20T01:31:00.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2024 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":76,"expiration_date":"2033-05-17","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-23-025828","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000114036123025828/form4.xml","form_type":"4"}},{"id":2061909,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chair of the Board"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-06T02:42:00.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":15834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option would have expired in approximately one month and would have been forfeited to the extent it was not exercised on or prior to January 29, 2023."}],"balance_after":0,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":15834},"source":{"system":"sec-edgar","filing":"0001567619-23-000574","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761923000574/doc1.xml","form_type":"4"}},{"id":2061908,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-01-06T02:42:00.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":69,"price":60.8467,"value":4198.4223,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The transaction was executed in multiple trades in prices ranging from $60.77 to $61.00, inclusive."}],"balance_after":243,"source":{"system":"sec-edgar","filing":"0001567619-23-000574","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761923000574/doc1.xml","form_type":"4"}},{"id":2061907,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-01-06T02:42:00.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":10,"price":59.46,"value":594.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":312,"source":{"system":"sec-edgar","filing":"0001567619-23-000574","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761923000574/doc1.xml","form_type":"4"}},{"id":2061906,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-01-06T02:42:00.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":1523,"price":58.6692,"value":89353.1916,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The transaction was executed in multiple trades in prices ranging from $58.195 to $58.92, inclusive."}],"balance_after":322,"source":{"system":"sec-edgar","filing":"0001567619-23-000574","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761923000574/doc1.xml","form_type":"4"}},{"id":2061905,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-01-06T02:42:00.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":1303,"price":56.9789,"value":74243.5067,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $56.76 to $57.31, inclusive."}],"balance_after":1845,"source":{"system":"sec-edgar","filing":"0001567619-23-000574","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761923000574/doc1.xml","form_type":"4"}},{"id":2061904,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-01-06T02:42:00.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":6621,"price":56.3314,"value":372970.1994,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $55.76 to $56.755, inclusive."}],"balance_after":3148,"source":{"system":"sec-edgar","filing":"0001567619-23-000574","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761923000574/doc1.xml","form_type":"4"}},{"id":2061903,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-01-06T02:42:00.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":2897,"price":55.3472,"value":160340.8384,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $54.75 to $55.74, inclusive."}],"balance_after":9769,"source":{"system":"sec-edgar","filing":"0001567619-23-000574","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761923000574/doc1.xml","form_type":"4"}},{"id":2061902,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-01-06T02:42:00.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":3411,"price":54.1503,"value":184706.6733,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $53.74 to $54.68, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 7 of this Form 4."}],"balance_after":12666,"source":{"system":"sec-edgar","filing":"0001567619-23-000574","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761923000574/doc1.xml","form_type":"4"}},{"id":2061901,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-01-06T02:42:00.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":15834,"price":6.41,"value":101495.94,"ownership":{"direct":true},"balance_after":16077,"source":{"system":"sec-edgar","filing":"0001567619-23-000574","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761923000574/doc1.xml","form_type":"4"}},{"id":2097905,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"other":true,"other_text":"Chair of the Board"}}],"security":"Stock Option (right to buy)","published_at":"2022-12-03T02:30:26.000Z","date":"2022-12-01","kind":"exercise","acquired":false,"shares":15834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately two months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."}],"balance_after":15834,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":15834},"source":{"system":"sec-edgar","filing":"0001140361-22-044319","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000114036122044319/form4.xml","form_type":"4"}},{"id":2097904,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-12-03T02:30:26.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":6021,"price":62.119,"value":374018.499,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $61.66 to $62.62, inclusive."}],"balance_after":243,"source":{"system":"sec-edgar","filing":"0001140361-22-044319","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000114036122044319/form4.xml","form_type":"4"}},{"id":2097903,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-12-03T02:30:26.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":9813,"price":61.2848,"value":601387.7424,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $60.65 to $61.6475, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 and 3 of this Form 4."}],"balance_after":6264,"source":{"system":"sec-edgar","filing":"0001140361-22-044319","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000114036122044319/form4.xml","form_type":"4"}},{"id":2097902,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-12-03T02:30:26.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":15834,"price":6.41,"value":101495.94,"ownership":{"direct":true},"balance_after":16077,"source":{"system":"sec-edgar","filing":"0001140361-22-044319","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000114036122044319/form4.xml","form_type":"4"}},{"id":2125237,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"other":true,"other_text":"Chair of the Board"}}],"security":"Stock Option (right to buy)","published_at":"2022-11-04T01:31:44.000Z","date":"2022-11-01","kind":"exercise","acquired":false,"shares":15833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately three months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."}],"balance_after":31668,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":15833},"source":{"system":"sec-edgar","filing":"0001140361-22-039911","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000114036122039911/form4.xml","form_type":"4"}},{"id":2125236,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-11-04T01:31:44.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":1661,"price":64.9414,"value":107867.6654,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $64.86 to $65.16, inclusive."}],"balance_after":243,"source":{"system":"sec-edgar","filing":"0001140361-22-039911","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000114036122039911/form4.xml","form_type":"4"}},{"id":2125235,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-11-04T01:31:44.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":3312,"price":64.2586,"value":212824.4832,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $63.83 to $64.815, inclusive."}],"balance_after":1904,"source":{"system":"sec-edgar","filing":"0001140361-22-039911","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000114036122039911/form4.xml","form_type":"4"}},{"id":2125234,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-11-04T01:31:44.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":1717,"price":62.9079,"value":108012.8643,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $62.57 to $63.27, inclusive."}],"balance_after":5216,"source":{"system":"sec-edgar","filing":"0001140361-22-039911","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000114036122039911/form4.xml","form_type":"4"}},{"id":2125233,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-11-04T01:31:44.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":9143,"price":62.0095,"value":566952.8585,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $61.56 to $62.54, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 5 of this Form 4."}],"balance_after":6933,"source":{"system":"sec-edgar","filing":"0001140361-22-039911","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000114036122039911/form4.xml","form_type":"4"}},{"id":2125232,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-11-04T01:31:44.000Z","date":"2022-11-01","kind":"exercise","acquired":true,"shares":15833,"price":6.41,"value":101489.53,"ownership":{"direct":true},"balance_after":16076,"source":{"system":"sec-edgar","filing":"0001140361-22-039911","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000114036122039911/form4.xml","form_type":"4"}},{"id":2141961,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chair of the Board"}}],"security":"Stock Option (right to buy)","published_at":"2022-10-06T01:46:19.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":15833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately four months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."}],"balance_after":47501,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":15833},"source":{"system":"sec-edgar","filing":"0001567619-22-018291","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761922018291/doc1.xml","form_type":"4"}},{"id":2141960,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-06T01:46:19.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":1693,"price":62.9609,"value":106592.8037,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $62.66 to $63.47, inclusive."}],"balance_after":243,"source":{"system":"sec-edgar","filing":"0001567619-22-018291","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761922018291/doc1.xml","form_type":"4"}},{"id":2141959,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-06T01:46:19.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":6355,"price":62.105,"value":394677.275,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $61.61 to $62.47, inclusive."}],"balance_after":1936,"source":{"system":"sec-edgar","filing":"0001567619-22-018291","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761922018291/doc1.xml","form_type":"4"}},{"id":2141958,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-06T01:46:19.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":4277,"price":61.0726,"value":261207.5102,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $60.60 to $61.59, inclusive."}],"balance_after":8291,"source":{"system":"sec-edgar","filing":"0001567619-22-018291","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761922018291/doc1.xml","form_type":"4"}},{"id":2141957,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-06T01:46:19.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":3508,"price":60.3204,"value":211603.9632,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $59.60 to $60.59, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 5 of this Form 4."}],"balance_after":12568,"source":{"system":"sec-edgar","filing":"0001567619-22-018291","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761922018291/doc1.xml","form_type":"4"}},{"id":2141956,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-06T01:46:19.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":15833,"price":6.41,"value":101489.53,"ownership":{"direct":true},"balance_after":16076,"source":{"system":"sec-edgar","filing":"0001567619-22-018291","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761922018291/doc1.xml","form_type":"4"}},{"id":2148585,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"other":true,"other_text":"Chair of the Board"}}],"security":"Stock Option (right to buy)","published_at":"2022-10-01T01:30:56.000Z","date":"2022-09-28","kind":"exercise","acquired":false,"shares":31666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option are fully vested exercisable as of the date hereof."}],"balance_after":63334,"derivative":{"exercise_price":6.41,"expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":31666},"source":{"system":"sec-edgar","filing":"0001140361-22-035561","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000114036122035561/form4.xml","form_type":"4"}},{"id":2148584,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-01T01:30:56.000Z","date":"2022-09-28","kind":"sale","acquired":false,"shares":31666,"price":48.09,"value":1522817.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":243,"source":{"system":"sec-edgar","filing":"0001140361-22-035561","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000114036122035561/form4.xml","form_type":"4"}},{"id":2148583,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"other":true,"other_text":"Chair of the Board"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-01T01:30:56.000Z","date":"2022-09-28","kind":"exercise","acquired":true,"shares":31666,"price":6.41,"value":202979.06,"ownership":{"direct":true},"balance_after":31909,"source":{"system":"sec-edgar","filing":"0001140361-22-035561","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000114036122035561/form4.xml","form_type":"4"}},{"id":2219611,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-30T00:04:40.000Z","date":"2022-06-27","kind":"grant","acquired":true,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 27, 2022, the Reporting Person was granted 93,750 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the earlier of (i) the anniversary of the grant date of June 27, 2022 or (ii) the Issuer's annual general meeting of shareholders in such year."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":93750,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":93750},"source":{"system":"sec-edgar","filing":"0001562180-22-005402","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897448/000156218022005402/primarydocument.xml","form_type":"4"}},{"id":2219610,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-30T00:04:40.000Z","date":"2022-06-27","kind":"grant","acquired":true,"shares":115919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 27, 2022, the Reporting Person was granted an option to purchase 115,919 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the \"Plan\"). The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of June 27, 2022 or (ii) the Issuer's annual general meeting of shareholders in 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":115919,"derivative":{"exercise_price":1.92,"expiration_date":"2032-06-27","underlying":"Ordinary Shares","underlying_shares":115919},"source":{"system":"sec-edgar","filing":"0001562180-22-005402","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000156218022005402/primarydocument.xml","form_type":"4"}},{"id":2220019,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-28T17:53:43.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":6245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023."}],"balance_after":6245,"derivative":{"exercise_price":60.57,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":6245},"source":{"system":"sec-edgar","filing":"0001209191-22-039567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000120919122039567/doc4.xml","form_type":"4"}},{"id":2220018,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-28T17:53:43.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023."}],"balance_after":17745,"source":{"system":"sec-edgar","filing":"0001209191-22-039567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000120919122039567/doc4.xml","form_type":"4"}},{"id":2252870,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"other":true,"other_text":"Chair of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-28T01:30:25.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2023 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":25.6,"expiration_date":"2032-05-18","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-22-021103","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000114036122021103/form4.xml","form_type":"4"}},{"id":2653146,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-28T22:24:59.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":4125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022."}],"balance_after":4125,"derivative":{"exercise_price":93.2,"expiration_date":"2031-06-24","underlying":"Common Stock","underlying_shares":4125},"source":{"system":"sec-edgar","filing":"0001209191-21-043543","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000120919121043543/doc4.xml","form_type":"4"}},{"id":2653145,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T22:24:59.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":2145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022."}],"balance_after":14445,"source":{"system":"sec-edgar","filing":"0001209191-21-043543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000120919121043543/doc4.xml","form_type":"4"}},{"id":2667054,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-17T00:01:53.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 14, 2021, the Reporting Person was granted 38,000 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the earlier of (i) the anniversary of the grant date of June 14, 2021 or (ii) the Issuer's annual general meeting of shareholders in such year."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":38000,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001562180-21-004325","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897448/000156218021004325/primarydocument.xml","form_type":"4"}},{"id":2667053,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T00:01:53.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":48506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 14, 2021, the Reporting Person was granted an option to purchase 48,506 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the \"Plan\"). The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of June 14, 2021 or (ii) the Issuer's annual general meeting of shareholders in 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":48506,"derivative":{"exercise_price":5,"expiration_date":"2031-06-14","underlying":"Ordinary Shares","underlying_shares":48506},"source":{"system":"sec-edgar","filing":"0001562180-21-004325","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000156218021004325/primarydocument.xml","form_type":"4"}},{"id":2700469,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-21T21:03:52.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2022 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":23.97,"expiration_date":"2031-05-19","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-21-010955","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761921010955/doc1.xml","form_type":"4"}},{"id":2853653,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:43:35.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":6315,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017.  In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary."}],"balance_after":6315,"derivative":{"exercise_price":22.85,"expiration_date":"2027-05-18","underlying":"Ordinary Shares","underlying_shares":6315},"source":{"system":"sec-edgar","filing":"0001567619-21-004313","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761921004313/doc1.xml","form_type":"4"}},{"id":2853652,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:43:35.000Z","date":"2021-02-12","kind":"disposition_to_issuer","acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017.  In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share."}],"balance_after":0,"derivative":{"exercise_price":56.23,"exercise_date":"2018-05-14","expiration_date":"2027-05-18","underlying":"Ordinary Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001567619-21-004313","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761921004313/doc1.xml","form_type":"4"}},{"id":2853651,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:43:35.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":8426,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016.  In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary."}],"balance_after":8426,"derivative":{"exercise_price":22.85,"expiration_date":"2026-05-20","underlying":"Ordinary Shares","underlying_shares":8426},"source":{"system":"sec-edgar","filing":"0001567619-21-004313","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761921004313/doc1.xml","form_type":"4"}},{"id":2853650,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:43:35.000Z","date":"2021-02-12","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016.  In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share."}],"balance_after":0,"derivative":{"exercise_price":42.5,"exercise_date":"2017-05-16","expiration_date":"2026-05-20","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-21-004313","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761921004313/doc1.xml","form_type":"4"}},{"id":2853649,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:43:35.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":9803,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015.  In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary."}],"balance_after":9803,"derivative":{"exercise_price":22.85,"expiration_date":"2025-05-22","underlying":"Ordinary Shares","underlying_shares":9803},"source":{"system":"sec-edgar","filing":"0001567619-21-004313","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761921004313/doc1.xml","form_type":"4"}},{"id":2853648,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T23:43:35.000Z","date":"2021-02-12","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015.  In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share."}],"balance_after":0,"derivative":{"exercise_price":34.04,"exercise_date":"2016-05-18","expiration_date":"2025-05-22","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-21-004313","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761921004313/doc1.xml","form_type":"4"}},{"id":3082933,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-07-16T00:02:26.000Z","date":"2020-07-13","kind":"grant","acquired":true,"shares":28702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On July 13, 2020, the Reporting Person was granted 28,702 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the earlier of (i) the anniversary of the grant date of July 13, 2020 or (ii) the Issuer's annual general meeting of shareholders in such year."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":28702,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":28702},"source":{"system":"sec-edgar","filing":"0001562180-20-005122","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897448/000156218020005122/primarydocument.xml","form_type":"4"}},{"id":3082932,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-16T00:02:26.000Z","date":"2020-07-13","kind":"grant","acquired":true,"shares":36739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 13, 2020, the Reporting Person was granted an option to purchase 36,739 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the \"Plan\"). The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of July 13, 2020 or (ii) the Issuer's annual general meeting of shareholders in 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":36739,"derivative":{"exercise_price":6.62,"expiration_date":"2030-07-13","underlying":"Ordinary Shares","underlying_shares":36739},"source":{"system":"sec-edgar","filing":"0001562180-20-005122","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000156218020005122/primarydocument.xml","form_type":"4"}},{"id":3096384,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-30T17:11:47.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 26, 2021."}],"balance_after":4250,"derivative":{"exercise_price":76.58,"expiration_date":"2030-06-26","underlying":"Common Stock","underlying_shares":4250},"source":{"system":"sec-edgar","filing":"0001209191-20-039405","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000120919120039405/doc4.xml","form_type":"4"}},{"id":3096383,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-30T17:11:47.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":2550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 26, 2021"}],"balance_after":12300,"source":{"system":"sec-edgar","filing":"0001209191-20-039405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000120919120039405/doc4.xml","form_type":"4"}},{"id":3136706,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-22T20:37:45.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2021 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":17500,"derivative":{"exercise_price":11.33,"expiration_date":"2030-05-20","underlying":"Ordinary Shares","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001567619-20-011030","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761920011030/doc1.xml","form_type":"4"}},{"id":3338436,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-17T21:40:11.000Z","date":"2019-12-17","kind":"disposition_to_issuer","acquired":false,"shares":37203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option."}],"balance_after":0,"derivative":{"exercise_price":3.45,"expiration_date":"2024-08-11","underlying":"Common Stock","underlying_shares":37203},"source":{"system":"sec-edgar","filing":"0000899243-19-029428","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000089924319029428/doc4.xml","form_type":"4"}},{"id":3338435,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-17T21:40:11.000Z","date":"2019-12-17","kind":"disposition_to_issuer","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option."}],"balance_after":0,"derivative":{"exercise_price":56.22,"expiration_date":"2026-05-31","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000899243-19-029428","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000089924319029428/doc4.xml","form_type":"4"}},{"id":3338434,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-17T21:40:11.000Z","date":"2019-12-17","kind":"disposition_to_issuer","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option."}],"balance_after":0,"derivative":{"exercise_price":50.93,"expiration_date":"2027-05-30","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000899243-19-029428","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000089924319029428/doc4.xml","form_type":"4"}},{"id":3338433,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-17T21:40:11.000Z","date":"2019-12-17","kind":"disposition_to_issuer","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option."}],"balance_after":0,"derivative":{"exercise_price":81.53,"expiration_date":"2028-05-29","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000899243-19-029428","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000089924319029428/doc4.xml","form_type":"4"}},{"id":3338432,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-17T21:40:11.000Z","date":"2019-12-17","kind":"other","acquired":false,"shares":3000,"price":114.5,"value":343500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated February 22, 2019, by and between Spark Therapeutics, Inc. (\"Spark\"), Roche Holdings, Inc. (\"Roche\") and 022019 Merger Subsidiary, Inc. (\"Merger Sub\") (the \"Merger Agreement\" and the transactions contemplated thereby, the \"Merger\"), whereby Roche caused Merger Sub to conduct a tender offer for all of the issued and outstanding shares of common stock, par value $0.001 per share, of Spark, at a price of $114.50 per share. On December 17, 2019, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-029428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000089924319029428/doc4.xml","form_type":"4"}},{"id":3373496,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-14T01:05:17.000Z","date":"2019-11-12","kind":"exercise","acquired":false,"shares":38600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option granted to the Reporting Person is fully vested as of the date hereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"exercise_price":14.4,"expiration_date":"2022-07-10","underlying":"Ordinary Shares","underlying_shares":38600},"source":{"system":"sec-edgar","filing":"0001209191-19-056488","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119056488/doc4.xml","form_type":"4"}},{"id":3373495,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-11-14T01:05:17.000Z","date":"2019-11-12","kind":"sale","acquired":false,"shares":38600,"price":19.3461,"value":746759.46,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Please see the section titled \"Remarks\" below for additional information."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-056488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119056488/doc4.xml","form_type":"4"}},{"id":3373494,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-11-14T01:05:17.000Z","date":"2019-11-12","kind":"exercise","acquired":true,"shares":38600,"price":14.4,"value":555840.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":38600,"source":{"system":"sec-edgar","filing":"0001209191-19-056488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119056488/doc4.xml","form_type":"4"}},{"id":3378023,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-08T01:05:46.000Z","date":"2019-11-05","kind":"exercise","acquired":false,"shares":6400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option granted to the Reporting Person is fully vested as of the date hereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":38600,"derivative":{"exercise_price":14.4,"expiration_date":"2022-07-10","underlying":"Ordinary Shares","underlying_shares":6400},"source":{"system":"sec-edgar","filing":"0001209191-19-055751","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119055751/doc4.xml","form_type":"4"}},{"id":3378022,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-11-08T01:05:46.000Z","date":"2019-11-05","kind":"sale","acquired":false,"shares":6400,"price":18.0047,"value":115230.08,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Please see the section titled \"Remarks\" below for additional information."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-055751","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119055751/doc4.xml","form_type":"4"}},{"id":3378021,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-11-08T01:05:46.000Z","date":"2019-11-05","kind":"exercise","acquired":true,"shares":6400,"price":14.4,"value":92160.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":6400,"source":{"system":"sec-edgar","filing":"0001209191-19-055751","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119055751/doc4.xml","form_type":"4"}},{"id":3422414,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-06T00:04:35.000Z","date":"2019-09-03","kind":"exercise","acquired":false,"shares":51671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option granted to the Reporting Person is fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":3.21,"expiration_date":"2028-05-14","underlying":"Ordinary Shares","underlying_shares":51671},"source":{"system":"sec-edgar","filing":"0001209191-19-048659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119048659/doc4.xml","form_type":"4"}},{"id":3422413,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-06T00:04:35.000Z","date":"2019-09-03","kind":"exercise","acquired":false,"shares":25845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option granted to the Reporting Person is fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":3.06,"expiration_date":"2027-05-15","underlying":"Ordinary Shares","underlying_shares":25845},"source":{"system":"sec-edgar","filing":"0001209191-19-048659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119048659/doc4.xml","form_type":"4"}},{"id":3422412,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-06T00:04:35.000Z","date":"2019-09-03","kind":"exercise","acquired":false,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option granted to the Reporting Person is fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":5.58,"expiration_date":"2023-07-08","underlying":"Ordinary Shares","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001209191-19-048659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119048659/doc4.xml","form_type":"4"}},{"id":3422411,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-09-06T00:04:35.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":91016,"price":15.0053,"value":1365722.3848,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.70 to $15.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Please see the section titled \"Remarks\" below for additional information."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-048659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119048659/doc4.xml","form_type":"4"}},{"id":3422410,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-09-06T00:04:35.000Z","date":"2019-09-03","kind":"exercise","acquired":true,"shares":51671,"price":3.21,"value":165863.91,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":91016,"source":{"system":"sec-edgar","filing":"0001209191-19-048659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119048659/doc4.xml","form_type":"4"}},{"id":3422409,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-09-06T00:04:35.000Z","date":"2019-09-03","kind":"exercise","acquired":true,"shares":25845,"price":3.06,"value":79085.7,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":39345,"source":{"system":"sec-edgar","filing":"0001209191-19-048659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119048659/doc4.xml","form_type":"4"}},{"id":3422408,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-09-06T00:04:35.000Z","date":"2019-09-03","kind":"exercise","acquired":true,"shares":13500,"price":5.58,"value":75330.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001209191-19-048659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119048659/doc4.xml","form_type":"4"}},{"id":3475878,"issuer":{"id":152909,"kind":"organization","name":"SOPHIRIS BIO INC.","symbol":"SPHS"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-28T20:19:57.000Z","date":"2019-06-27","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Company 2017 Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to this option shall vest and become exercisable monthly over a one year period."}],"balance_after":20000,"derivative":{"exercise_price":0.7782,"exercise_date":"2019-07-27","expiration_date":"2029-06-26","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-039474","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000120919119039474/doc4.xml","form_type":"4"}},{"id":3490984,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-13T20:40:51.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 11, 2020."}],"balance_after":5000,"derivative":{"exercise_price":58.74,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-036806","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000120919119036806/doc4.xml","form_type":"4"}},{"id":3490983,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-13T20:40:51.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 11, 2020."}],"balance_after":9750,"source":{"system":"sec-edgar","filing":"0001209191-19-036806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000120919119036806/doc4.xml","form_type":"4"}},{"id":3504306,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-06-03T20:17:14.000Z","date":"2019-05-30","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 30, 2018, the reporting person was granted 1,500 restricted stock units that vest on the one-year anniversary of the grant date.  Vested shares are delivered to the reporting person on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 30, 2018, the reporting person was granted 1,500 restricted stock units that vest on the one-year anniversary of the grant date.  Vested shares are delivered to the reporting person on the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001609351-19-000056","document":"wf-form4_155959301909668.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000160935119000056/wf-form4_155959301909668.xml","form_type":"4"}},{"id":3504305,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-03T20:17:14.000Z","date":"2019-05-30","kind":"exercise","acquired":true,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit converted into one share of Spark Therapeutics, Inc. common stock."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001609351-19-000056","document":"wf-form4_155959301909668.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000160935119000056/wf-form4_155959301909668.xml","form_type":"4"}},{"id":3511500,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-24T20:05:28.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2020 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":17500,"derivative":{"exercise_price":9.23,"expiration_date":"2029-05-22","underlying":"Ordinary Shares","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001567619-19-012070","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376117/000156761919012070/doc1.xml","form_type":"4"}},{"id":3517414,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-22T00:02:36.000Z","date":"2019-05-20","kind":"grant","acquired":true,"shares":8023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 20, 2019, the Reporting Person was granted 8,023 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the earlier of (i) the anniversary of the grant date of May 20, 2019 or (ii) the Issuer's annual general meeting of shareholders in such year."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":8023,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":8023},"source":{"system":"sec-edgar","filing":"0001209191-19-031858","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119031858/doc4.xml","form_type":"4"}},{"id":3517413,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-22T00:02:36.000Z","date":"2019-05-20","kind":"grant","acquired":true,"shares":10431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 20, 2019, the Reporting Person was granted an option to purchase 10,431 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the \"Plan\"). The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of May 20, 2019 or (ii) the Issuer's annual general meeting of shareholders in 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":10431,"derivative":{"exercise_price":16.83,"expiration_date":"2029-05-20","underlying":"Ordinary Shares","underlying_shares":10431},"source":{"system":"sec-edgar","filing":"0001209191-19-031858","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119031858/doc4.xml","form_type":"4"}},{"id":3609718,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-07T01:16:15.000Z","date":"2019-03-04","kind":"exercise","acquired":false,"shares":28287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option granted to the Reporting Person is fully vested as of the date hereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"exercise_price":2.5,"expiration_date":"2025-07-06","underlying":"Ordinary Shares","underlying_shares":28287},"source":{"system":"sec-edgar","filing":"0001209191-19-017567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119017567/doc4.xml","form_type":"4"}},{"id":3609717,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-07T01:16:15.000Z","date":"2019-03-04","kind":"exercise","acquired":false,"shares":17358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option granted to the Reporting Person is fully vested as of the date hereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"exercise_price":2.5,"expiration_date":"2025-07-06","underlying":"Ordinary Shares","underlying_shares":17358},"source":{"system":"sec-edgar","filing":"0001209191-19-017567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119017567/doc4.xml","form_type":"4"}},{"id":3609716,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-07T01:16:15.000Z","date":"2019-03-04","kind":"exercise","acquired":false,"shares":35258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option granted to the Reporting Person is fully vested as of the date hereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"exercise_price":2.19,"expiration_date":"2026-07-11","underlying":"Ordinary Shares","underlying_shares":35258},"source":{"system":"sec-edgar","filing":"0001209191-19-017567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119017567/doc4.xml","form_type":"4"}},{"id":3609715,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-07T01:16:15.000Z","date":"2019-03-04","kind":"exercise","acquired":false,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option granted to the Reporting Person is fully vested as of the date hereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"exercise_price":1.87,"expiration_date":"2024-03-11","underlying":"Ordinary Shares","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001209191-19-017567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119017567/doc4.xml","form_type":"4"}},{"id":3609714,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-07T01:16:15.000Z","date":"2019-03-04","kind":"exercise","acquired":false,"shares":6390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option granted to the Reporting Person is fully vested as of the date hereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"exercise_price":1.87,"expiration_date":"2024-03-11","underlying":"Ordinary Shares","underlying_shares":6390},"source":{"system":"sec-edgar","filing":"0001209191-19-017567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119017567/doc4.xml","form_type":"4"}},{"id":3609713,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-07T01:16:15.000Z","date":"2019-03-04","kind":"exercise","acquired":false,"shares":19584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option granted to the Reporting Person is fully vested as of the date hereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"exercise_price":1.03,"expiration_date":"2020-02-10","underlying":"Ordinary Shares","underlying_shares":19584},"source":{"system":"sec-edgar","filing":"0001209191-19-017567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119017567/doc4.xml","form_type":"4"}},{"id":3609712,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-03-07T01:16:15.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":36700,"price":21.712,"value":796830.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted in 2018 by the Reporting Person in accordance with the requirements for such plans described in the Company's Annual Report on Form 10-K."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.48 to $22.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Please see the section titled \"Remarks\" below for additional information."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-017567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119017567/doc4.xml","form_type":"4"}},{"id":3609711,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-03-07T01:16:15.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":98677,"price":21.1607,"value":2088074.3939,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted in 2018 by the Reporting Person in accordance with the requirements for such plans described in the Company's Annual Report on Form 10-K."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.48 to $21.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":36700,"source":{"system":"sec-edgar","filing":"0001209191-19-017567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119017567/doc4.xml","form_type":"4"}},{"id":3609710,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-03-07T01:16:15.000Z","date":"2019-03-04","kind":"exercise","acquired":true,"shares":28287,"price":2.5,"value":70717.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted in 2018 by the Reporting Person in accordance with the requirements for such plans described in the Company's Annual Report on Form 10-K."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":135377,"source":{"system":"sec-edgar","filing":"0001209191-19-017567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119017567/doc4.xml","form_type":"4"}},{"id":3609709,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-03-07T01:16:15.000Z","date":"2019-03-04","kind":"exercise","acquired":true,"shares":17358,"price":2.5,"value":43395.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted in 2018 by the Reporting Person in accordance with the requirements for such plans described in the Company's Annual Report on Form 10-K."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":107090,"source":{"system":"sec-edgar","filing":"0001209191-19-017567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119017567/doc4.xml","form_type":"4"}},{"id":3609708,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-03-07T01:16:15.000Z","date":"2019-03-04","kind":"exercise","acquired":true,"shares":35258,"price":2.19,"value":77215.02,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted in 2018 by the Reporting Person in accordance with the requirements for such plans described in the Company's Annual Report on Form 10-K."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":89732,"source":{"system":"sec-edgar","filing":"0001209191-19-017567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119017567/doc4.xml","form_type":"4"}},{"id":3609707,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-03-07T01:16:15.000Z","date":"2019-03-04","kind":"exercise","acquired":true,"shares":28500,"price":1.87,"value":53295.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted in 2018 by the Reporting Person in accordance with the requirements for such plans described in the Company's Annual Report on Form 10-K."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":54474,"source":{"system":"sec-edgar","filing":"0001209191-19-017567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119017567/doc4.xml","form_type":"4"}},{"id":3609706,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-03-07T01:16:15.000Z","date":"2019-03-04","kind":"exercise","acquired":true,"shares":6390,"price":1.87,"value":11949.3,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted in 2018 by the Reporting Person in accordance with the requirements for such plans described in the Company's Annual Report on Form 10-K."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":25974,"source":{"system":"sec-edgar","filing":"0001209191-19-017567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119017567/doc4.xml","form_type":"4"}},{"id":3609705,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-03-07T01:16:15.000Z","date":"2019-03-04","kind":"exercise","acquired":true,"shares":19584,"price":1.03,"value":20171.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted in 2018 by the Reporting Person in accordance with the requirements for such plans described in the Company's Annual Report on Form 10-K."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":19584,"source":{"system":"sec-edgar","filing":"0001209191-19-017567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119017567/doc4.xml","form_type":"4"}},{"id":3697695,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-12T01:16:04.000Z","date":"2019-01-10","kind":"exercise","acquired":false,"shares":100416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option granted to the Reporting Person is fully vested as of the date hereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":19584,"derivative":{"exercise_price":1.03,"expiration_date":"2020-02-10","underlying":"Ordinary Shares","underlying_shares":100416},"source":{"system":"sec-edgar","filing":"0001209191-19-003496","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119003496/doc4.xml","form_type":"4"}},{"id":3697694,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-01-12T01:16:04.000Z","date":"2019-01-10","kind":"sale","acquired":false,"shares":7496,"price":18.6236,"value":139602.5056,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.57 to $18.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-003496","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119003496/doc4.xml","form_type":"4"}},{"id":3697693,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-01-12T01:16:04.000Z","date":"2019-01-10","kind":"sale","acquired":false,"shares":55762,"price":18.1606,"value":1012671.3772,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.57 to $18.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":7496,"source":{"system":"sec-edgar","filing":"0001209191-19-003496","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119003496/doc4.xml","form_type":"4"}},{"id":3697692,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-01-12T01:16:04.000Z","date":"2019-01-10","kind":"sale","acquired":false,"shares":48711,"price":17.2885,"value":842140.1235,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.57 to $17.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":63258,"source":{"system":"sec-edgar","filing":"0001209191-19-003496","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119003496/doc4.xml","form_type":"4"}},{"id":3697691,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-01-12T01:16:04.000Z","date":"2019-01-10","kind":"sale","acquired":false,"shares":7247,"price":15.9622,"value":115678.0634,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.51 to $16.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":111969,"source":{"system":"sec-edgar","filing":"0001209191-19-003496","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119003496/doc4.xml","form_type":"4"}},{"id":3697690,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-01-12T01:16:04.000Z","date":"2019-01-10","kind":"sale","acquired":false,"shares":21200,"price":14.9244,"value":316397.28,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.49 to $15.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":119216,"source":{"system":"sec-edgar","filing":"0001209191-19-003496","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119003496/doc4.xml","form_type":"4"}},{"id":3697689,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":46830,"kind":"person","name":"Ekman Lars","position":1,"cik":"0001376117","reported_name":"Ekman Lars","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-01-12T01:16:04.000Z","date":"2019-01-10","kind":"exercise","acquired":true,"shares":100416,"price":1.03,"value":103428.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"security","element":"securityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":140416,"source":{"system":"sec-edgar","filing":"0001209191-19-003496","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919119003496/doc4.xml","form_type":"4"}}],"next_cursor":"2019-01-12T01:16:04.000000Z,3697689"}